A Genetically Engineered Macrophage-Derived Vesicular Nanodecoy Targeting the CD47/SIRPα Axis for Reinforced Tumor Radioimmunotherapy
ACS Nano · 2026-06-09 · 20 (22) · 16470-16487
DOI: 10.1021/acsnano.6c06363 ↗At a glance
Journal article in ACS Nano, published online on 2026-05-28. Written by Jinqiao Zhang and 8 co-authors. Institution: School of Life and Health Sciences, Hunan University of Science and Technology, Xiangtan 411201, P. R. China. Major MEDLINE topics: CD47 Antigen, Radioimmunotherapy, Macrophages, Receptors, Immunologic. 54 references. Funded by: Shandong First Medical University, Natural Science Foundation of Jiangsu Province, Taishan Scholar Project of Shandong Province.
Abstract (original language)
No hay resumen disponible.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Life and Health Sciences, Hunan University of Science and Technology, Xiangtan 411201, P. R. China.
- Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medicine Sciences, Jinan, Shandong 250117, P. R. China.
- State Key Laboratory of Flexible Electronics (LoFE) & Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommunications, Nanjing, Jiangsu 210000, P. R. China.
ORCID profiles: Ziliang Dong
Funding
- Shandong First Medical University
- Natural Science Foundation of Jiangsu Province
- Taishan Scholar Project of Shandong Province
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China (NSFC)
Cite
APA
Zhang, J., Tong, T., Cai, C., Cai, X., Sun, B., Wen, K., Qu, X., Fan, Q., & Dong, Z. (2026). A Genetically Engineered Macrophage-Derived Vesicular Nanodecoy Targeting the CD47/SIRPα Axis for Reinforced Tumor Radioimmunotherapy. ACS Nano, 20(22), 16470-16487. https://doi.org/10.1021/acsnano.6c06363
Vancouver
Zhang J, Tong T, Cai C, Cai X, Sun B, Wen K, et al. A Genetically Engineered Macrophage-Derived Vesicular Nanodecoy Targeting the CD47/SIRPα Axis for Reinforced Tumor Radioimmunotherapy. ACS Nano. 2026;20(22):16470-16487. doi:10.1021/acsnano.6c06363
BibTeX
@article{Zhang2026,
author = {Zhang, Jinqiao and Tong, Ting and Cai, Chang and Cai, Xianzhou and Sun, Bicheng and Wen, Kexin and Qu, Xinran and Fan, Qin and Dong, Ziliang},
title = {A Genetically Engineered Macrophage-Derived Vesicular Nanodecoy Targeting the CD47/SIRPα Axis for Reinforced Tumor Radioimmunotherapy},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {22},
pages = {16470--16487},
doi = {10.1021/acsnano.6c06363}
}
EUVIMED